tm
Seeing Is Believing
tm
Seeing Is Believing
RNAZ is currently covered by 1 analysts with an average price target of $1.83. This is a potential upside of $1.55 (553.57%) from yesterday's end of day stock price of $0.28.
Transcode Therapeutics's activity chart (see below) currently has 0 price targets and 5 ratings on display. The stock rating distribution of RNAZ is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 138 days.
Highest price target for RNAZ is $3, Lowest price target is $3, average price target is $1.83.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 29-May-2024. First documented stock forecast 07-Jun-2022.
Currently out of the existing stock ratings of RNAZ, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$1.99 (197.03%)
$3
6 months 4 days ago
(29-May-2024)
2/4 (50%)
$1.55 (106.90%)
138
What is RNAZ (Transcode Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RNAZ (Transcode Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RNAZ (Transcode Therapeutics)?
Which analyst is the currently most bullish on RNAZ (Transcode Therapeutics)?
